Madhukar Pai

McGill Global Health Programs
Madhukar Pai

Prof. Madhukar Pai (MD, PhD, FCAHS) is a Canada Research Chair in Epidemiology & Global Health at McGill University, Montreal. He is the Director of McGill Global Health Programs, and Associate Director of the McGill International TB (tuberculosis) Centre.

Madhu Pai did his medical training and community medicine residency in Vellore, India. He completed his Ph.D. in epidemiology at University of California, Berkeley, and a postdoctoral fellowship at the University of California, San Francisco.

Madhu serves as a Consultant to the Bill & Melinda Gates Foundation. He serves on the STAG-TB (Strategic and Technical Advisory Group for Tuberculosis) committee of WHO, Geneva; Scientific Advisory Committee of FIND (Foundation for Innovative New Diagnostics), Geneva; and Access Advisory Committee of TB Alliance, New York. He serves as the Chair of the Public-Private Mix (PPM) Working Group of the Stop TB Partnership. He is on the editorial boards of Lancet Infectious Diseases, PLoS Medicine, eLife, PLoS ONE, International Journal of TB and Lung Disease, among others.

Madhu’s research is mainly focussed on improving the diagnosis and treatment of tuberculosis, especially in high-burden countries like India and South Africa. His research is supported by grant funding from the Gates Foundation, Grand Challenges Canada, and Canadian Institutes of Health Research. He has more than 300 publications. He is recipient of the Union Scientific Prize, Chanchlani Global Health Research Award, Haile T. Debas Prize, and David Johnston Faculty & Staff Award. He is a member of the Royal Society of Canada, and a Fellow of the Canadian Academy of Health Sciences.

Posts by

Madhukar Pai

Button Text
No items found.
No items found.

How can immigrant scientists give back to their homelands?

In addition to contributing to their adopted countries, immigrant scientists have potential to use their talents to give back to their homelands. In this context, Madhukar Pai shares his personal experience in India, and provides insights that may be applicable to immigrant scientists from other countries.

14 June 2018
Human Development
Human Development

India's plan to eliminate tuberculosis by 2025: Converting rhetoric into reality

During the 2017 Union Budget address, the Government of India announced its plan to eliminate tuberculosis (TB) by 2025, which is extraordinarily ambitious given that India accounts for a large proportion of new TB cases and deaths globally. In this article, Pai, Bhaumik and Bhuyan offer some suggestions that might help bridge the gap between ambition and reality.

24 January 2018
Human Development
Human Development
No items found.
No items found.
No items found.
No items found.
No items found.
No items found.
No items found.
No items found.
No items found.

Sign up to our newsletter to be notified about the latest updates

Thank you! Your submission has been received!
Your email ID is safe with us. We do not spam.